Kuhlmann et al. showed that G-CSF/SCF treatment partially reversed down-regulation of Cx43 expression in the border zone of infarction, resulting in reduced ventricular arrhythmia inducibility during ex vivo stimulation [33]. The gene discussed is GJA1; the disease is infarction.